With the development of simulation platforms able to reproduce glucose variability characterizing the T1D population, such as the UVA/Padova T1DS,17 clinical head-to-head comparisons of different insulin treatments can be performed to evaluate efficacy and safety in a cost-effective way. Here, INS is linked to type 1 diabetes mellitus.